Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services

Benzingajust now

Sanofi: Kress Was the CEO of MorphoSys From 2019 Until It Was Acquired by Novartis in 2024

Dow Jones01:06

Novartis will close MorphoSys's factories in Germany and the USA.

According to Reuters on December 19, the Swiss pharmaceutical group Novartis announced on Thursday that it will close the German Biotechnology company MorphoSys's factories in Germany and the USA, acquired earlier this year, affecting approximately 330 positions. A company spokesperson stated that the plan is to exit the factories in Munich and Boston by the end of 2025 and to consolidate all portfolio activities into Novartis.

Gelonghui FinanceDec 19 21:25

Market Chatter: Novartis to Close MorphoSys Sites, Affecting 330 Jobs

MT NewswiresDec 19 20:47

Novartis AG (NOVN) Gets a Sell From Barclays

TipRanksDec 19 18:45 · Ratings

The prospects of European Medical Care stocks are complex, with USA policies and new drug trial results being the key factors.

After falling from a high position in the last few months of 2024, European Medical Care stocks face the risks of US politics and the results of high-risk new drug trials in the new year.

Zhitong FinanceDec 19 14:48